Determination of LY217332, A New 3'-Quaternary Ammonium Cephalosporin,In Plasma by Solid Phase Column Extraction and HPLC

Abstract

A sensitive and rapid assay has been developed for the determination of LY217332, a 3'-imidazolo[4,5-c]pyridinium cephalosporin, in plasma. The method utilizes cyano solid phase column extraction and HPLC with ultraviolet detection. The lower limit of detection is 5 ng/ml plasma and the relative standard deviation for precision and accuracy was 5% or less from 50–500 ng/ml. The method is applicable to the assay of ceftazidime, cephaloridine, cefpirome and BMY-28142 with minor modification of the mobile phase and the detection wavelength.     

An Improved HPLC Method for the Determination of Furosemide in Plasma and Urine

Abstract

A sensitive HPLC method with minimal sample preparation and good reproducibility for the determination of furosemide in plasma and urine is described. Acidified plasma samples were extracted using CH₂Cl₂ containing desmethylnaproxen as internal standard (IS). Fresh urine samples were incubated with β-gluc-uronidase for 15 minutes and then treated with CH₃CN containing IS.

Chromatography was performed on a C18 column with 10 mcl sample injection, Mobile phases were: a) for plasma: 0.01 M NaH₂PO₄, pH 3.5 - CH₃OH (65:35), and b) for urine: acetic acid, pH 3.5 - CHS3OH (60:40) at 3 ml/min and fluorescence detection at Ex 235/Em 389 nm. The plasma standard curve was linear from 0.01 to 15.0 mcg/ml and the urine from 0.5 to 200.0 mcg/ml. The within run CV's were 3,2% at 0.74 mcg/ml plasma and 2.0% at 10.7 mcg/ml urine. Recovery from plasma was 69.9% at 2.0 mcg/ml and 98.6% from urine at 5.0 mcg/ml. The stability of furosemide and its glucuronide were studied. Both methods have been applied to the analysis of plasma and urine samples obtained from human volunteers.     

Second Derivative Spectrophotometric Determination of p-Aminophenol in the Presence of Paracetamol

Abstract

A second derivative spectroscopic method for the determination of p-aminophenol in paracetamol powder is described. Second derivative absorbance (d²A/dλ²) values were measured at 223.8 nm (Δ = 4.2 nm) where p-aminophenol showed derivative responses obeying Beer's Law but paracetamol had negligible derivative absorption. The concentrations of p-aminophenol solutions prepared in 0.1 N HCl (0.12–7.61 mcg/ml), containing constant amounts of paracetamol (20 mcg/ml) related linearly with the d²A/dλ² values and gave a straight line (r = ?0.9999). The method allowed determination of 0.5% to 38% of p-aminophenol in paracetamol without prior separation, it is rapid, precise and accurate.     

High Performance Liquid Chromatographic Determination of Phenacemide in Biological Fluids

Abstract

A sensitive and reliable high performance liquid chromatographic procedure has been developed for the quantitation of phenacemide in plasma or urine. After simple extraction of the drug with ethylacetate from alkalinized samples and evaporation to dryness, the reconstituted extract was chromatographed using a C₈ reversed phase analytical column with UV detection at 254 nm. Regression analyses for the calibration plots obtained on 3 different days for the drug concentrations ranging 1–15 mcg/ml indicated excellent linearity (r >0.999) and reproducibility (CV< 4%, p >0.01). The mean recovery of spiked phenacemide in plasma and urine from the lower limit of quantitation (1 mcg/ml) to 15 mcg/ml was 97.9 and 96.3%, respectively and their respective CV was 3.53 and 2.58%. The method was applied to monitor the plasma vs. time profile of the drug following a single bolus IV dose of 12 mg/kg in a dog.     

Quantitation of Cyproheptadine in Plasma and Urine by HPLC

Abstract

A sensitive, reliable and specific high performance liquid chromatographic procedure has been developed for the quantitation of cyproheptadine in plasma or urine. After extraction of the drug with ethyl acetate from alkalinized samples, the organic extract was evaporated to dryness, reconstituted with acetonitrile and chromatographed using a C₈ reversed-phase analytical column with UV detection at 254 nm. The average recoveries of cyproheptadine from spiked plasma and urine samples in the concentrations ranging from 0.2 – 3 mcg/ml were 95.7 and 100.3%, respectively and their respective CV was 4.1 and 3.9%. Regression analyses for the calibration plots for plasma and urine standards obtained on three different days for the drug concentrations between 0.2 – 3 mcg/ml indicated excellent linearity (r > 0.999) and reproducibility (CV < 2.0%, p > 0.01). The limit of sensitivity was 50 ng/ml for both plasma and urine samples. The method was applied to monitor the plasma concentration versus time profile of cyproheptadine following a single bolus IV dose of 1 mg/kg in a dog.

Urine samples taken from a human subject for the duration of 24 hours following a single oral dose of 8 mg showed that the cumulative amount excreted in urine as cyproheptadine was approximately 1% of the dose.     

Improved and Rapid Liquid Chromatographic Determination of Indomethacin in Serum

Abstract

A rapid, specific and sensitive reversed-phase liquid chromatographic (LC) assay for the quantitative determination of indomethacin in serum without extraction was developed. Chromatographic separation using flunixin meglumine as the internal standard was achieved on octadecylsilane-coated particles with a mobile phase of 0.15 M acetate buffer pH 3.0 (50% v/v), acetonitrile (30% v/v) and methanol (20% v/v). The recovery of indomethacin from serum samples in the concentration range of 0.1-25 μg/ml was 95.5 ± 5.8% and as little as 100 ng/ml of indomethacin in serum samples can be quantitated by this procedure. A serum level versus time profile of dog with intravenously administered indomethacin demonstrated the applicability of the assay.     

Quantitative Analysis of Meclizine in Tablet Formulations by HPLC

Abstract

A simple, rapid and precise high-performance liquid chromatographic assay of meclizine in tablets has been developed. Reversed-phase chromatography was conducted using a mobile phase of acetonitrile and water (30% V/V) and detection at 230 nm. The recovery and coefficient of variation from six placebo tablets containing 25 mg of meclizine were 100.5% and 0.84%, respectively. Replicate regression analyses of three standard plots in the concentration range of 1–12 mcg/ml obtained on three different days gave a correlation coefficient >0.998 and the coefficient of variation of the slopes <1%. The assay was precise within day and between days as indicated by ANOVA test. The recoveries from 10 replicate tablets of the two different commercial meclizine brands were 98.5 and 100.7% of the label amount and their coefficients of variation were 1.16 and 1.71%.     

Revised HPLC Determination of Atenolol in Plasma and Urine

Abstract

An HPLC method for analysis of atenolol in human plasma and urine is presented. Based on alkaline extraction, acid backextraction and reverse phase ion-pair chromatography this method is quite specific for atenolol. For a 0.5 ml plasma sample the sensitivity ranges from 20 ng/ml in fasted healthy volunteers to 50 ng/ml in various groups of patients. A sensitivity in urine of 1.0 mcg/ml was sufficient for all samples studied. As presented this method has been used in several clinical pharmacokinetic studies involving hundreds of samples.     

Ion-Pair Liquid Chromatographic Analysis of Phenylpropanolamine in Plasma and Urine by Post-Column Derivatization with O-Phthalaldehyde

Abstract

A high pressure Liquid chromatographic analysis of phenylpropano Lamine in plasma and urine by post-column derivatzaition with o-phthalaldehyde is described. Plasma samples are extracted with methylene chloride under alkaline conditions. Urine is diluted with mobile phase without extraction. Using fluorescence detection, the method is sufficiently sensitive (2 ng/ml in 0.5 ml of plasma and 0.5 mcg/ml in 0.2 ml of urine) so that phenylpropano lamine concentrations in plasma or urine may be measured for up to 24 hours following a 75 mg oral dose. Coefficients of variation for inter-day and intra-day precision are less than 10%.     

Determination of ceftazidime in dolphin serum by liquid chromatography with ultraviolet-visible detection and confirmation by thermospray liquid chromatography-mass spectrometry.

A simple and sensitive liquid chromatographic method has been developed for the determination of therapeutic levels of ceftazidime in dolphin serum. The method involved an ultrafiltration of diluted serum with an equal amount of acetonitrile-ethanol-water (40:40:20, v/v/v) through a 10,000 daltons molecular mass cut-off filter. Separation of ceftazidime from the other serum components was performed by ion-paired (dodecanesulfonate) liquid chromatography using a reversed-phase column eluted with acetonitrile-water solution. The ultraviolet absorbance of the column effluent was monitored in the 200-340 nm range of a photodiode-array detector or at 258.8 nm on a variable-wavelength ultraviolet-visible detector. Recoveries of ceftazidime from dolphin serum spiked with 20 and 2 micrograms/ml were 92.9 and 91.1% with coefficients of variation of 5.5 and 5.7%, respectively. A correlation coefficient of 0.9994 occurred with ceftazidime in aqueous solutions (n = 6, in duplicates). The limit of detection for this antibiotic was estimated to be approximately 50 ppb (ng/ml). The unbound ceftazidime concentrations in dosed dolphin serum were determined to calculate the protein bindings of this antibiotic which yielded 32 +/- 2%. The ceftazidime peak identity in dosed dolphin serum was confirmed by thermospray liquid chromatography-mass spectrometry. The thermospray mass spectrum of ceftazidime exhibited only the fragment ions, involving the opening of the beta-lactam ring, at m/z 237, 255 and 315 when positive-ion detection mode was employed and the fragment ions at m/z 235, 253 and 313 when negative-ion detection mode was used.     

High-Pressure Liquid Chromatographic Assay of Azlocillin and Mezlocillin with an Anion-Exchange Extraction Technique

Abstract

An anion-exchange column deproteination technique has been employed with the high-pressure liquid chromatographic (LC) assay for azlocillin and mezlocillin. The anionexchange extraction gave excellent (97%-99%) drug recovery. Quantitation of antibiotics using the LC method compares favorably to the traditional biological assay technique with correlation coefficients for azlocillin = 0.998 and mezlocillin = 0.988. The anion-exchange extraction provides an interference-free chromatogram which aids in the LC assay of these drugs.     

Toxicokinetic and bioavailability studies on retrorsine in mice,and ketoconazole-induced alteration in toxicokinetic properties

Retrorsine (RTS) is a toxic retronecine-type pyrrolizidine alkaloid, which is widely distributed. The purpose of this study was to develop a high-performance liquid chromatography–tandem mass spectrometric (LC–MS/MS) method for serum RTS determination in mice. Serum samples were deproteinated by acetonitrile, separated on a C₁₈-PFP column and delivered at 0.8 ml/min with an eluting system composed of water containing 0.1% (v/v) formic acid and acetonitrile containing 0.1% (v/v) formic acid as mobile phases. RTS and the internal standard S-hexylglutathione (H-GSH) were quantitatively monitored with precursor-to-product transitions of m/z 352.1 → 120.1 and m/z 392.2 → 246.3, respectively. The method showed excellent linearity over the concentration range 0.05–50 μg/ml, with correlation coefficient r² = 0.9992. The extraction recovery was >86.34%, and the matrix effect was not significant. Inter- and intra-day precisions (RSD) were <4.99%. The validated LC–MS/MS method was successfully applied to study the toxicokinetic profiles of serum RTS in mice after intravenous, oral administration and co-treated with ketoconazole, which showed that RTS displayed a long half-life (~11.05 h) and good bioavailability (81.80%). Co-administration of ketoconazole (KTZ) increased the peak serum concentration and area under the concentration–time curve and decreased the clearance and mean residence time. Summing up, a new standardized method was established for quantitative determination of RTS in sera.     

Simultaneous Quantification of Ceftazidime and Pyridine,its Main Degradation Product,by High-Performance Liquid Chromatography

ABSTRACT

A high performance liquid chromatographic method for the simultaneous assay of ceftazidime and pyridine, the principal degradation product of ceftazidime, is described. The method was fully validated in terms of recovery, linearity, selectivity and precision. An application was done on stability of ceftazidime at 40 mg.mL¹ in infusion solutions 0.9% NaCl and 5% glucose on 24 hours in ambulatory infusion device. Quantification results of pyridine were more linear and accurate than ceftazidime. Pyridine was a good label in ceftazidime stability studies.     

Determination of Penicillinase-Resistant Penicillins In Serum Using High-Pressure Liquid Chromatography

Abstract

A method for the determination of methicillin, oxacillin, cloxacillin, dicloxacillin, and nafcillin in serum using high-pressure liquid chromatography (HPLC) is described. The drugs were extracted from serum using a two-step procedure employing acetonitrile followed by methylene chloride. The extraction procedure concentrated the antibiotics in a smaller volume which allows more accurate determinations of low serum levels. The treated sera were analyzed by HPLC on a reverse-phase column and detected by ultraviolet light absorption at 254 nm. Serum concentrations were measurable as low as 0.5 μg/ml. Recovery procedures showed less than 2.5% variation in peak heights when the antibiotics were extracted from different pools of serum. No interfering absorption was found in extracts of serum samples pooled from healthy volunteers, from a commercial source, or from two serum pools from patients receiving a variety of other drugs. Two spiked serum specimens prepared for each antibiotic were assayed four times by HPLC and by the microbiological agar diffusion method. No significant statistical differences between the methods were observed. Control materials were assayed for between-batch and within-batch reproducibility in the presence or absence of an internal standard. Results for between-batch reproducibility demonstrate CV's of about 5%. This procedure provides a sensitive, specific, accurate, and rapid method for determining antibiotic levels in routine clinical specimens.     

The Estimation of Serum Digoxin by Combined HPLC Separation and Radioimmunological Assay

Abstract

A specific method for the quantitation of digoxin in serum has been developed and applied to determination of drug concentrations in serum from digitalized patients. One ml of the supernatant from acetonitrile denatured serum, subsequently diluted with water, was chromatographed on a reversed phase HPLC column. The eluent corresponding to the retention time of digoxin was collected and analysed using a commercial radioimmunoassay kit. The recovery at 3ng/ml was 96.1 ± 3.0%. Endogenous substances, drugs and metabolites of digoxin do not interfere with the method. The mean value of the samples estimated by the present method was 84% of those determined by direct R.I.A.     

Pre-column derivatization method for determining phenylephrine in human plasma and its application in a pharmacokinetic study

In the present study, a rapid derivatization liquid chromatography–tandem mass spectrometry (LC–MS/MS) method was developed and validated to evaluate phenylephrine in human plasma. The plasma samples were processed to precipitate the proteins, followed by derivatization of the phenylephrine in the plasma with dansyl-chloride solution and extraction with methyl tert-butyl ether–n-hexane (2:1, v/v). The treated samples were analyzed on a Gemini C₁₈ column with 3 min gradient elution, and sensitive detection was achieved with a Waters TQ-s. The method gave linear results over a concentration range from 0.020 to 10.0 ng/ml. The lower limit of quantification was 0.020 ng/ml. Intra- and inter-day precision was <15%, and accuracy was 95.0–105.3%. The validated LC–MS/MS method was successfully applied in the pharmacokinetic analysis of phenylephrine in Chinese subjects with common cold after a single-dose administration of 5, 10 or 20 mg phenylephrine. This pre-column derivatization method may also be applied for the analysis of endogenous hormones such as norepinephrine and adrenaline in a biological matrix.     

A Rapid HPLC Method for Determination of Imipenem in Plasma

Abstract

A high performance liquid chromatographic method was developed for the determination of imipenem concentrations in plasma. This method involves stabilization of plasma with a mixture of 2-(N-morpholine)-ethanesulf onic acid and ethylene glycol (1:1). Samples are ultrafiltered using a membrane separation system and the ultrafiltrate injected directly onto a octyldecyl column. Chromatography is performed in the reverse-phase mode with a mobile phase of acetonitrile-phosphate buffer-triethylamine (pH 7.0). The lower limit of sensitivity was 1mcg/ml using UV detection at 300nm. Recovery and reproducibility results, and interferences from other therapeutic agents are presented and discussed. The assay procedure is applied to estimate pharmacokinetic parameters of imipenem in a thermally injured patient.     

Ion-Paired Liquid Chromatographic Determination of Cefazolin in Canine Serum and Tissues

Abstract

Cefazolin is commonly used as a prophylactic antibiotic in dogs undergoing total hip arthroplasty.

A sensitive high-performance liquid chromatographic method was developed for the determination of cefazolin in canine serum and tissues. The tissues were those in contact with the hip prothesis; namely, the coxofemoral joint capsule, cancellous bone from the acetabulum and bone marrow from the femoral canal.

The method involved filtration of diluted serum or tissue extracted with ethanol:acetonitrile:water (40:10:50) through a 30,000 molecular weight cut-off filter. Separation of cefazolin from other components was by ion-paired (dodecanosulfonate) high performance liquid chromatography using a reversed-phase column eluted with acetonitrile/water solution. The ultraviolet absorbance of the column effluent was monitored at 230 nm. Recovery of cefazolin spiked at 10 μg/ml from serum was 89.8% with a coefficient of variation (CV) of 5.3% (n=10). Recovery of cefazolin spiked at 5 μg/ml from tissue extracts of joint capsule, cancellous bone and bone marrow was: 93.9%, 98.2%, and 104.2% respectively, with a CV of 6.7%, 10.2% and 10.6% respectively (n=10). A correlation coefficient of 0.9999 occurred with cefazolin in aqueous solution (n=5). The limit of detection for cefazolin was approximately 10 ng/ml of serum or tissue extract.     

High-Performance Liquid Chromatographic Determination of Ceftazidime in Serum,Urine, CSF,and Peritoneal Dialysis Fluid

Abstract

A rapid, sensitive and specific high performance liquid chromatographic method is described for the determination of ceftazidime in serum, urine, CSF and peritoneal dialysis fluid. The procedure employs reversed-phase chromatography, using hydrochlorothiazide as an internal standard. The assay only requires 100 μl of sample with direct injection of diluted urine, CSF, peritoneal dialysis fluid or protein precipitated serum. Stability studies indicate good drug recovery if urine and serum are stored under proper conditions. The method is specific for ceftazidime in the presence of amikacin, gentamicin, kanamycin, tobramycin, methicillin, penicillin G, ampicillin, chloramphenicol and caffeine. The method has been successfully employed in the assay of over 700 samples obtained during human clinical trials.     

Gas Liquid Chromatographic Determination of Caffeine in Breast Milk and Blood Plasma

Abstract

An improved procedure for the determination of caffeine in the presence of bupivicaine (internal standard) using gas liquid chromatography with nitrogen phosphorous detection is described. The method is based on the extraction of caffeine from plasma with a mixture of chloroform and isopropanol (95:5). The chloroform and isopropanol mixture is evaporated to dryness and the residue dissolved in 500 μl of ethyl acetate. One to 2 μl samples are injected directly into the gas chromatograph. This extraction process doesn't give rise to troublesome interfering peaks in the chromatogram. The recovery of caffeine from plasma and breast milk is approximately 99.7% and 94.1% respectively. The coefficient variation of the assay from plasma and breast milk is 2.90% and 1.18% respectively. The limit of quantitation is 0.05 mcg/ml of plasma or breast milk. Data are presented to illustrate the practicality of the method for bioavailability and pharmacokinetic evaluation of caffeine plasma and breast milk levels after oral administration of 100 mg of caffeine to lactating mothers.